This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone quarter ended Sep 2026: revenue down 8.8 percent, profit after tax turns to loss
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 3.2 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone for the quarter ended 30 September 2026, revenue from operations fell to Rs 863.97 lakh from Rs 946.82 lakh a year earlier, while profit after tax moved to a loss of Rs 29.45 lakh from a profit of Rs 14.96 lakh. Standalone half-year loss after tax narrowed to Rs 29.17 lakh from Rs 59.15 lakh. Standalone EBITDA margin fell to 0.2 percent from 3.1 percent. Borrowings were Rs 1,062.64 lakh; equity was negative Rs 340.26 lakh.
Lower revenue, a quarterly loss and negative equity raise financial risk and may pressure the stock, despite positive half-year cash from operations.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹8.64 Cr | ₹9.47 Cr | −8.8% |
| Operating profit | −₹0.45 Cr | −₹0.21 Cr | loss widened |
| Profit after tax | −₹0.29 Cr | ₹0.15 Cr | −296.9% |
| EBITDA margin | 0.3% | 3.1% | −2.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.